Validation of existing and development of new prognostic classification schemes in node negative breast cancer

Breast Cancer Research and Treatment

Volumn 42, Issue 2, 1997, Pages 149-163

  Sauerbrei, Willi ^a   Hübner, Klaus ^b   Schmoor, Claudia ^a   Schumacher, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Breast cancer; Classification schemes; Measure of separation; Node negative; Recurrence free survival; Validation

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 0031036070     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005733404976     Document Type: Article

References (48)

1. Glick JH, Gelber RD, Goldhirsch A, Senn HJ: Meeting highlights: Adjuvant therapy for primary breast cancer. J Natl Cancer Inst 84: 1479-1485, 1992
2. Rubens RD: Management of early breast cancer. Br Med J 304: 1361-1364, 1992
3. Haybittle JL, Blamey RW, Elston CW et al.: A prognostic index in primary breast cancer. Br J Cancer 45: 361-366, 1982
4. Sigurdsson H, Baldetorp B, Borg A et al.: Indicators of prognosis in node-negative breast cancer. N Engl J Med 322: 1045-1053, 1990
5. O'Reilly SM, Camplejohn RS, Barnes RR et al.: Node-negative breast cancer: Prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol 8: 2040-2046, 1990a
6. Chevallier B, Mosseri V, Dauce JP et al.: A prognostic score in histological node negative breast cancer. Br J Cancer 61: 436-440, 1990
7. Henson D, Ries L, Freedman LS, Carriaga M: Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. Cancer 68: 2142-2149, 1991
8. Aaltomaa S, Lipponen P, Eskelinen M et al.: Predictive value of a morphometric prognostic index in female breast cancer. Oncology 50: 57-62, 1993
9. Balslev I. Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT: The Nottingham Prognostic Index applied to 9149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 32: 281-290, 1994
10. O'Reilly SM, Richards MA: Node-negative breast cancer. Adjuvant chemotherapy should probably be reserved for patients at high risk of release. Br Med J 300: 346-348, 1990b
11. McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326: 1756-1761, 1992
12. Cox DR: Regression models and life tables (with discussion). J Roy Stat Soc B 34: 187-220, 1972
13. Breiman L, Friedman JH, Ohlsen RA, Stone CJ: Classification and regression trees. Wadsworth, Belmont, 1984
14. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 2: 359-377, 1957
15. Todd JH, Dowle CS, Williams MR: Confirmation of prognostic index in primary breast cancer. Br J Cancer 56: 489-492, 1987
16. Galea MH, Blamey RW, Elston CE, Ellis IO: The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22: 207-219, 1992
17. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: the value of histologic grade in breast cancer: experience from a large study with long term follow-up. Histopathology 19: 403-410, 1991
18. Byar DP: Identification of prognostic factors. In: Buyse ME, Staquet MJ, Sylvester RJ (eds) Cancer Clinical Trials - Methods and Practice. Oxford University Press. Oxford. 1984, pp 423-443
19. Peto R, Pike MC, Armitage NE et al.: Design and analysis of clinical trials requiring prolonged observation of each patient. Part I: Br J Cancer 34: 585-612, 1976. Part II: Br J Cancer 35: 1-39, 1977
20. Peto R, Pike MC, Armitage NE et al.: Design and analysis of clinical trials requiring prolonged observation of each patient. Part I: Br J Cancer 34: 585-612, 1976. Part II: Br J Cancer 35: 1-39, 1977
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
22. Lausen B, Sauerbrei W, Schumaeher M: Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales. In: Dirschedl R, Ostermann R (eds) Computational Statistics. Physica-Verlag, Berlin, 1994
23. SAS Institute Inc.: SAS User's Guide: Statistics. Version 6, Cary, NC. 1991
24. Nissen-Meyer R, Host H, Kjellgren K, Mansson B, Norin T: Short perioperative versus long-term adjuvant chemotherapy. Rec Results Cancer Res 98: 91-98, 1985
25. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T: Surgical adjuvant chemotherapy - results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 41: 2088-2098, 1978
26. The Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320: 491-496, 1989
27. Bojar H: Quality control requirements in estrogen receptor determination. Cancer Res 44: 4249-4250, 1986
28. Goldhirsch A, Wood WC, Senn H-J, Glick JH, Gelber RD: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 87: 1441-1445, 1995
29. Gasparini G, Pozza F, Harris AL: Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 85: 1206-1219, 1993
30. Altman DG, Lausen B, Sauerbrei W, Schumacher M: Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835, 1994
31. Hedley DW, Clark GM, Cornelisse CJ et al.: Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 14: 482-485, 1993
32. Brown JM, Benson EA, Jones M: Confirmation of a long-term prognostic index in breast cancer. Breast 2: 144-147, 1993
33. Miller WR, Ellis IO, Sainsbury JRC, Dixon JM: ABC of breast diseases: Prognostic factors. Br Med J 309: 1573-1576, 1994
34. Neville AM, Bettelheim R, Gelber RD, Säve-Süderberght J, Davis BW et al.: Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. J Clin Oncol 10: 696-705, 1992
35. De la Rochefordiere A, Asselain B, Campana F et al.: Age as prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039-1043, 1993
36. Richards MA, Gregory WM, Smith P et al.: Age as prognostic factor in premenopausal breast cancer. Lancet 341: 1484-1485, 1993
37. Albain KS, Allred DC, Clark GM: Breast cancer outcome and predictors of outcome: are there age differentials? Monographs - National Cancer Institute 16: 35-42, 1994
38. Fowble BL, Schultz DJ, Overmoyer B et al.: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30: 23-33, 1994
39. Crowe JP, Gordon NH, Shenk RR et al.: Age does not predict breast cancer outcome (with discussion). Archiv Surg 129: 483-488, 1994
40. Nixon AJ, Neuberg D, Hayes DF et al.: Relationship of patient age to pathologic features of the tumor prognosis for patients with state I or II breast cancer. J Clin Oncol 12: 888-894, 1994
41. Thorpe SM, Christensen IJ, Rasmussen BB, Rose C: Short recurrence-free survival associated with high estrogen receptor levels in the natural history of postmenopausal, primary breast cancer. Eur J Cane 29A: 971-977, 1993
42. Romain S, Chinot O, Guirou O, Soullière M, Martin PM: Biological heterogeneity of ER-positive breast cancers in the post-menopausal population. Int J Cancer 59: 17-19, 1994
43. Fisher ER, Redmond C, Fisher B et al.: Prognostic factors in NSABP studies of women with node-negative breast cancer. Consensus Development Conference on the Treatment of Early-Stage Breast Cancer. J Natl Cancer Inst Monograph 11: 151-158, 1992
44. Korn EL, Simon R: Measures of explained variation for survival analysis. Stat Med 9: 487-503, 1990
45. Schemper M: The explained variation in proportional hazards regression. Biometrika 77: 216-218, 1990
46. Loprinzi CL, Ravelin PM, De Laurentiis M, Novotny P: Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol 12: 1422-1426, 1994
47. McGuire WL: Breast cancer prognostic factors - Evaluation guidelines. J Natl Cancer Inst 83: 154-155, 1991
48. Hatschek T, Groentoft O, Fagerberg G et al.: Cytometric and histopathologic features of tumors detected in a randomized mammography screening program - Correlation and relative prognostic influence. Breast Cancer Res Treat 15: 149-160, 1990